Register entry
- Registered sites
- 0
- Active NDC listings
- 2
- Labeller names
- 2
- Live patents
- 0
- Countries
- 0
Catalogue
Drug listings by form and route
22 active NDC listings: 1 bulk ingredient, 1 human prescription drug. By marketing category: BULK INGREDIENT 1, NDA 1.
| Dosage form | NDCs |
|---|---|
| injection, powder, for solution | 1 |
| powder | 1 |
| Route | NDCs |
|---|---|
| intravenous | 1 |
| Labeller name on the listing | NDCs |
|---|---|
| celcuity | 1 |
| celcuity inc. | 1 |
Catalogue
Marketed products
2| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| - | Gedatolisib | powder | 84577-750BULK INGREDIENT |
| REVTORPYK | gedatolisib | injection, powder, for solution, intravenous | 84577-751NDA |
Enquiry
Common questions
- Is Celcuity Inc. FDA approved?
- Celcuity Inc. holds no registered establishment of its own; 2 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Celcuity Inc. make?
- 2 products are listed under Celcuity Inc. in the openFDA NDC Directory, most often as injection, powder, for solution; powder. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.